YDES (YD Bio) ROIC %: -194.35% (As of Dec. 2025)


YDES YD Bio Ltd YDES
12 GF Score
Price $2.01
! 1 Warning Sign
View Full Analysis

What is YD Bio ROIC %?

YD Bio YDES -17.62% 12 ROIC % is -194.35% as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. YD Bio's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2025 was -194.35%.

As of today (2026-07-02), YD Bio's WACC % is 10.49%. YD Bio's ROIC % is -110.31% (calculated using TTM income statement data). YD Bio earns returns that do not match up to its cost of capital. It will destroy value as it grows.

YD Bio  (NAS:YDES) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, YD Bio's WACC % is 10.49%. YD Bio's ROIC % is -110.31% (calculated using TTM income statement data). YD Bio earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

YD Bio ROIC % Related Terms

YD Bio ROIC % Historical Data

* Premium members only.

The historical data trend for YD Bio's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YD Bio ROIC % Chart

YD Bio Annual Data
Trend Dec23 Dec24 Dec25
ROIC %
0.00 -41.94 -109.16

YD Bio Semi-Annual Data
Dec24 Jun25 Dec25
ROIC % 0.00 -0.05 -194.35

YDES vs CRBU, ABOS, PRQR: ROIC % Comparison

For the Biotechnology subindustry, YD Bio's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YD Bio ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, YD Bio's ROIC % distribution charts can be found below:

* The bar in red indicates where YD Bio's ROIC % falls into.


YDES
12GF Score
YD Bio Ltd YDES
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

YD Bio ROIC % Calculation

YD Bio's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-5.268 * ( 1 - 0.02% )/( (3.486 + 6.164)/ 2 )
=-5.2669464/4.825
=-109.16 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6.864 - 0.246 - ( 3.132 - max(0, 0.263 - 3.468+3.132))
=3.486

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=13.779 - 1.607 - ( 6.008 - max(0, 1.644 - 9.67+6.008))
=6.164

YD Bio's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2025 is calculated as:

ROIC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-10.534 * ( 1 - 0.02% )/( (4.674 + 6.164)/ 2 )
=-10.5318932/5.419
=-194.35 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5.841 - 0.697 - ( 0.47 - max(0, 0.753 - 1.397+0.47))
=4.674

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=13.779 - 1.607 - ( 6.008 - max(0, 1.644 - 9.67+6.008))
=6.164

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -194.35% mean?
YD Bio (YDES) has a ROIC % of -194.35% as of Dec. 2025. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on YD Bio and its competitors.
Is YD Bio's ROIC % too high?
YD Bio's current ROIC % is -194.35%. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's ROIC % compare to CRBU and ABOS?
YD Bio's ROIC % of -194.35% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Biotechnology company?
A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on YD Bio and its competitors. YD Bio's current ROIC % is -194.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current ROIC % of -194.35%. The current ROIC % is -194.35%. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For YD Bio (YDES), the current ROIC % is -194.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

YD Bio Business Description

Address No. 3, Xingnan Street, 12th Floor, Nangang District, Taipei City, TWN, 115001
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score

Get the complete analysis for YDES

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.01
Price